Silver M S, Counts G W, Zeleznik D, Turck M
Antimicrob Agents Chemother. 1977 Nov;12(5):591-6. doi: 10.1128/AAC.12.5.591.
Cefaclor, a new oral cephalosporin, was compared in vitro with cephalexin and cephradine against 233 organisms. Evaluations were performed in Mueller-Hinton and nutrient broth and agar using two inoculum sizes. In agar, cefaclor had greater antibacterial activity than either cephalexin or cephradine against isolates of Escherichia coli, Proteus mirabilis, Staphylococcus aureus, Klebsiella pneumoniae, and Salmonella typhi. All three drugs were relatively inactive against isolates of enterococci, Enterobacter species, and indole-positive Proteus. Cefaclor, however, did exhibit the greatest activity of the three antibiotics against these organisms. Although there was wide variability with respect to test parameters, the broth results generally paralleled the agar results. In nutrient broth a clear separation of the results with these three cephalosporins was seen with K. pneumoniae, E. coli, and S. typhi. Cefaclor was the most active, cephalexin had intermediate activity, and cephradine was the least active. From the data obtained in this in vitro study, it can be concluded that cefaclor, which has a substituted chloro group attached to the molecule, had increased antibacterial activity over cephalexin and cephradine. Comparative clinical trials with cefaclor will determine whether the differences outlined above are of clinical significance.
新型口服头孢菌素头孢克洛,在体外与头孢氨苄和头孢拉定针对233种微生物进行了比较。在穆勒-欣顿培养基、营养肉汤和琼脂中使用两种接种量进行评估。在琼脂中,头孢克洛对大肠杆菌、奇异变形杆菌、金黄色葡萄球菌、肺炎克雷伯菌和伤寒沙门菌的抗菌活性比头孢氨苄或头孢拉定都强。这三种药物对肠球菌、肠杆菌属和吲哚阳性变形杆菌的分离株相对无活性。然而,头孢克洛在这三种抗生素中对这些微生物的活性最强。尽管测试参数存在很大差异,但肉汤结果总体上与琼脂结果相似。在营养肉汤中,肺炎克雷伯菌、大肠杆菌和伤寒沙门菌对这三种头孢菌素的结果有明显区分。头孢克洛活性最强,头孢氨苄活性中等,头孢拉定活性最弱。从这项体外研究获得的数据可以得出结论,分子上带有取代氯基团的头孢克洛比头孢氨苄和头孢拉定具有更高的抗菌活性。头孢克洛的比较临床试验将确定上述差异是否具有临床意义。